Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients

References

• Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352:804–15.
   PubMed Web of Science ®Google Scholar
• Allen JC, Talab F, Zuzel M, Lin K, Slupsky JR. c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells. Blood 2011;117:2414–22.
   PubMedGoogle Scholar
• Consoli U, Santonocito A, Stagno F, Fiumara P, PriviteraA, Parisi G, . Multidrug resistance mechanisms in chronic lymphocytic leukemia. Br J Haematol 2002; 116:774–80.
   PubMed Web of Science ®Google Scholar
• Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, . Functional polymorphisms of the human multidrug resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97:3473–8.
   PubMed Web of Science ®Google Scholar
• Jamroziak K, Balcerczak E, Smolewski P, Robey RW, Cebula B, Panczyk M, . MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia. Pharmacological Report 2006;58:720–8.
   PubMed Web of Science ®Google Scholar
• Goreva OB, Grishanova AY, Mukhin OV, Domnikova NP, Lyakhovich VV. Possible prediction of the efficiency of chemotherapy in patients with lymphoproliferative diseases based on MDR1 gene G2677T and C3435T polymorphisms. Bull Exp Biol Med 2003;136:183–5.
   PubMed Web of Science ®Google Scholar
• Houlston RS, Catovsky D, Yuille MR Genetic susceptibility to chronic lymphocytic leukemia. Leukemia 2002;16:1008–14.
   PubMed Web of Science ®Google Scholar
• Lynch HT, Weisenburger DD, Quinn-Laquer B, Watson P, Lynch JF, Sanger WG.Hereditary chronic lymphocytic leukemia: An extended family study and literature review. Am J Med Genet 2002;115:113–7.
   PubMedGoogle Scholar
• Penna G, Allegra A, Alonci A, Aguennouz M, Garufi A, Cannavò A, . MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: An impact on susceptibility and prognosis. Med Oncol Epub 2010 May 22.
   Web of Science ®Google Scholar
• Pawlik A, Baskiewicz-Masiuk M, Machalinski B, Kurzawski M, Gawronska-Szklarz B. Involvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. Eur J Pharmacol 2005; 528:27–36.
   PubMed Web of Science ®Google Scholar
• Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, Sun WJ, . Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cancer Lett 2010;295:110–23.
   PubMed Web of Science ®Google Scholar
• Dumoutier L, Van Roost E, Colau D. Human interleukin-10-related T cell derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 2000;97:10144–9.
   PubMed Web of Science ®Google Scholar
• Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, . Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor related proteins CRF2-4 and IL-22R. J Biol Chem 2000;275:31335–9.
   PubMed Web of Science ®Google Scholar
• Hsu HS, Huang PI, Chang YL, Tzao C, Chen YW, Shih HC, . Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells. Cancer 2011;117:2970–85;
   PubMed Web of Science ®Google Scholar
• Bard JD, Gelebart P, Anand M, Amin HM, Lai R. Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma. Leukemia 2008;22:1595–603.
   PubMed Web of Science ®Google Scholar
• Dumoutier L, de Meester C, Tavernier J, Renauld JC.New activation modus of STAT3: A tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain. J Biol Chem 2009;284:26377–84.
   PubMedGoogle Scholar
• Lyng H, Landsverk KS, Kristiansen E, DeAngelisPM, Ree AH, Myklebost O, .Response of malignant B lymphocytes to ionizing radiation: Gene expression and genotype. Int J Cancer2005;115:935–42.
   PubMed Web of Science ®Google Scholar
• Gelebart P, Zak Z, Dien-Bard J, Anand M, Lai R. Interleukin 22 signaling promotes cell growth in mantle cell lymphoma. Transl Oncol 2011;4:9–19.
   PubMed Web of Science ®Google Scholar